Jatinder Dhaliwal
Interim CFO, CEO & DirectorMr. Jatinder Dhaliwal, also known as Jay, serves as Chief Executive Officer and Director of Virpax Pharmaceuticals, Inc since October 06, 2024 and served as its Chairman since January 17, 2025 until 2025 and serves as its Interim Chief Financial Officer and Director since 2025. He was Director of BioRestorative Therapies, Inc. from June 12, 2026 to November 6, 2026. He serves as an Independent Director of NAVCO Pharmaceuticals Inc since January 18, 2024. He was an Independent Director of LQR House Inc. from August 21, 2023 until October 2024. He has served as interim CEO of Ravenquest Biomed Inc, since May 2020. He served as Director of Kiaro Holdings Corp. from July 21, 2022 to May 2023 and served as its Chief Executive Officer since August 10, 2022 until May 2023. He has been an Independent Director of Akanda Corp. since July 2022. He was the Chief Executive Officer and Director of EGF Theramed Health Corp. since 2020 until August 18, 2022. He served as a Director at Makara Mining Corp. since August 23, 2021 until September 7, 2022. He served as the CEO and Director of Global Health Clinics Ltd. since March 22, 2019 until June 29, 2026. He serves as Chief Executive Officer at Binovi Technologies Corp. since December 31, 2021 and serves as its Interim Chief Financial Officer since June 14, 2022. He serves as Director of Binovi Technologies Corp. since January 27, 2022. Mr. Dhaliwal served as Director of Intact Gold Corporation since August 9, 2019 until June 1, 2020. Previously, Mr. Dhaliwal served as a Pharmacy Manager from July 2015 to November 2019 for Rexall Pharmacy Group, as director from August 2021 to March 2022 of Makara Mining Corp, a junior mineral exploration company engaged in the business of acquiring, exploring and evaluating natural resource properties, as CEO and director from January 2020 to August 2022 of EGF Theramed Health Corp, a consumer technology company engaged in the provision of biomedical on-line services for monitoring and treating common health problems, as director from November 2019 to January 2020 of Intact Gold Corp, a junior mineral exploration company, as CEO and director from August 2022 to May 2023 of Kiaro Holdings Corp, an independent, omnichannel cannabis retailer and distributor. He served as an Interim CEO of Global Health Clinics Ltd. since March 2019. Mr. Dhaliwal served as a Director at Ravenquest Biomed Inc. since November 2019 until 2020 and also served as its Chief Financial Officer. Mr. Dhaliwal is a certified medical cannabis practitioner. Mr. Dhaliwal is a registered pharmacist practicing in British Columbia. Mr. Dhaliwal holds a Bachelor of Science in biology from the University of Victoria and a Bachelor of Pharmacy from the University of British Columbia. He served as Independent Director of Virpax Pharmaceuticals, Inc. from July 2024 until October 06, 2024.
公司职务
- 公司名称Virpax Pharmaceuticals, Inc.股票代码VRPX职务Interim CFO, CEO & Director
- 公司名称Akanda Corp.股票代码AKAN职务Independent Director
